World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
27878
World Ranking
13181
National Ranking
6717

Overview

David H. Abramson is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the field of Medicine, with significant work in Ophthalmology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research, and Molecular Biology. Abramson's contributions have focused extensively on ocular oncology and treatments, cancer-related molecular pathways, cancer genomics and diagnostics, brain metastases and treatment, glioma diagnosis and treatment, neuroblastoma research and treatments, and histiocytic disorders and treatments.

Their recent publications reflect a focus on cancer genomics, pediatric solid tumors, retinoblastoma, and melanoma progression. Notable papers include:

  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors (2021, Nature Cancer)
  • Treatment of Retinoblastoma: What Is the Latest and What Is the Future (2022, Frontiers in Oncology)
  • Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression (2021, Nature Communications)
  • Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience (2020, Cancer Medicine)
  • Immune Checkpoint Inhibitor-Associated Optic Neuritis (2020, Ophthalmology)

Frequent co-authors collaborating with Abramson include:

  • Jasmine H. Francis
  • Julia Canestraro
  • Ira J. Dunkel
  • Guillermo Chantada
  • Y. Pierre Gobin

These collaborations have contributed to a substantial publication record, especially in well-known clinical and research journals. Among the most common publication venues are:

  • Ophthalmology
  • Journal of Pediatric Ophthalmology & Strabismus
  • Pediatric Blood & Cancer
  • Ophthalmology Retina
  • American Journal of Ophthalmology Case Reports

Abramson's work is centered around clinical and molecular aspects of ocular and pediatric cancers, emphasizing early detection, treatment modalities, and molecular diagnostics. Their research intersects multiple disciplines including ophthalmology and oncology, highlighting translational applications in pediatric oncology and ocular cancer treatments. The volume and diversity of Abramson's publications indicate a broad engagement with both clinical and laboratory research communities, addressing complex cancer-related molecular pathways and therapeutic approaches.

Best Publications

  • Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk

    FL Wong;JD Boice;DH Abramson;RE Tarone

  • Germline mutations in BAP1 predispose to melanocytic tumors

    Thomas Wiesner;Anna C Obenauf;Anna C Obenauf;Rajmohan Murali;Isabella Fried

  • Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma

    Charis Eng;Frederick P. Li;David H. Abramson;Robert M. Ellsworth

  • Second Nonocular Tumors in Retinoblastoma Survivors: Are They Radiation-induced?

    Abramson Dh;Ellsworth Rm;Kitchin Fd;Tung G

  • A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

    David H. Abramson;David H. Abramson;Ira J. Dunkel;Scott E. Brodie;Scott E. Brodie;Scott E. Brodie;Jonathan W. Kim

  • Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up

    Ruth A. Kleinerman;Margaret A. Tucker;Robert E. Tarone;David H. Abramson

  • Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience

    Y. Pierre Gobin;Ira J. Dunkel;Brian P. Marr;Scott E. Brodie

  • Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial

    Richard D. Carvajal;Jeffrey A. Sosman;Jorge Fernando Quevedo;Mohammed M. Milhem

  • Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.

    David H Abramson;Christopher M Frank

  • Presenting signs of retinoblastoma

    David H. Abramson;Christopher M. Frank;Mark Susman;Mary P. Whalen

  • Variates of survival in metastatic uveal melanoma.

    Petra Rietschel;Katherine S. Panageas;Christine Hanlon;Ami Patel

  • Update on retinoblastoma.

    David H Abramson;Amy C Schefler

  • Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. visual acuity after 3 years COMS report no. 16

    B. M. Melia;D. H. Abramson;D. M. Albert;H. C. Boldt

  • Nonocular cancer in retinoblastoma survivors.

    Abramson Dh;Ellsworth Rm;Zimmerman Le

  • Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

    B L Gallie;R M Ellsworth;D H Abramson;R A Phillips

  • Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival.

    David H Abramson;Katherine Beaverson;Poorab Sangani;Robin A Vora

  • Treatment of Retinoblastoma in 2015: Agreement and Disagreement

    David H. Abramson;Carol L. Shields;Francis L. Munier;Guillermo L. Chantada

  • Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma

    Ruth A. Kleinerman;Margaret A. Tucker;David H. Abramson;Johanna M. Seddon

  • Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)

    David H. Abramson;Ira J. Dunkel;Scott E. Brodie;Brian Marr

  • Mortality from Second Tumors Among Long-Term Survivors of Retinoblastoma

    C. Eng;F. P. Li;D. H. Abramson;R. M. Ellsworth

Frequent Co-Authors

Johanna M. Seddon
Johanna M. Seddon University of Massachusetts Chan Medical School
Suresh C. Jhanwar
Suresh C. Jhanwar Memorial Sloan Kettering Cancer Center
Margaret A. Tucker
Margaret A. Tucker National Institutes of Health
Kevin C. Oeffinger
Kevin C. Oeffinger Duke University
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Richard D. Carvajal
Richard D. Carvajal Columbia University
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Francis L. Munier
Francis L. Munier University of Lausanne
Carol L. Shields
Carol L. Shields Thomas Jefferson University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or supportive roles, there is a wide range of online degrees and career pathways in healthcare. From hands-on patient care to administrative specialties, online programs offer flexibility and affordability to meet different needs and goals.

Entry points such as medical billing and coding cost courses allow students to quickly enter healthcare administration by learning to manage medical records and insurance claims. For those aiming to become advanced clinicians, finding affordable np programs is essential to balance quality education with financial responsibility.

Nursing remains one of the most versatile fields, and affordable online nursing programs can lead to rewarding careers with strong job security. Ambitious nurses looking to advance can consider a doctorate in nursing education online programs, opening doors to leadership, research, or academic roles.

Exploring these online options can help prospective students chart a fulfilling path in the healthcare sector, whether as clinicians, educators, or healthcare administrators.

Best Scientists Citing David H. Abramson

Trending Scientists

Recently Published Articles